Before making recommendations for the health system to include a subsidised self-monitoring programme in Nepal, it is also imperative to explore self-monitoring practices in patients for whom self-monitoring is considered more useful, that is, patients with type 1 diabetes and those with T2D on insulin [2]. The gene discussed is INS; the disease is type 2 diabetes mellitus.